Establishment of a RILD model in C57BL/6J mice treated with precise radiotherapy
XIAO Huihui1, LIU Lingling2, ZHANG Yongkang2, YANG Miaomiao3,4, CUI Xiangli2, HU Zongtao2
1. Affiliated Cancer Hospital of Harbin Medical University, Harbin 150000 China; 2. Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei 230000 China; 3. The First Affiliated Hospital of Anhui Medical University, Hefei 230000 China; 4. Anhui Public Health Clinical Center, Hefei 230000 China
肖会会, 刘苓苓, 张永康, 杨苗苗, 崔相利, 胡宗涛. 精准放疗下C57BL/6J鼠放射性肝损伤模型的建立[J]. 中国辐射卫生, 2023, 32(6): 611-617.
XIAO Huihui, LIU Lingling, ZHANG Yongkang, YANG Miaomiao, CUI Xiangli, HU Zongtao. Establishment of a RILD model in C57BL/6J mice treated with precise radiotherapy. Chinese Journal of Radiological Health, 2023, 32(6): 611-617.
[1] Chen GW, Zhao QQ, Yuan BY, et al. ALKBH5-Modified HMGB1-STING activation contributes to radiation induced liver disease via innate immune response[J]. Int J Radiat Oncol Biol Phys, 2021, 111(2): 491-501. DOI: 10.1016/J.IJROBP.2021.05.115 [2] Lee J, Shin IS, Yoon WS, et al. Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: meta-analyses and a systematic review[J]. Radiother Oncol, 2020, 145: 63-70. DOI: 10.1016/J.RADONC.2019.12.004 [3] 牛世英, 丛昌盛, 孙美丽, 等. 冷诱导RNA结合蛋白在放射性肺损伤模型中的表达变化[J]. 中国辐射卫生,2022,31(1):33-38,46. DOI: 10.13491/j.issn.1004-714X.2022.01.007 Niu SY, Cong CS, Sun ML, et al. Expression of cold-inducible RNA-binding protein in radiation-induced lung injury model[J]. Chin J Radiol Health, 2022, 31(1): 33-38,46. DOI: 10.13491/j.issn.1004-714X.2022.01.007 [4] 耿爽, 李倩, 郗停停, 等. 补体在放射性肺损伤中的作用与机制[J]. 中国辐射卫生,2022,31(5):535-541. DOI: 10.13491/j.issn.1004-714X.2022.05.002 Geng S, Li Q, Xi TT, et al. Role of complement in radiation-induced lung injury[J]. Chin J Radiol Health, 2022, 31(5): 535-541. DOI: 10.13491/j.issn.1004-714X.2022.05.002 [5] Wang YF, Dai YH, Lin CS, et al. Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series[J]. Radiat Oncol, 2021, 16(1): 15. DOI: 10.1186/S13014-020-01739-5 [6] Schaub SK, Hartvigson PE, Lock MI, et al. Stereotactic body radiation therapy for hepatocellular carcinoma: current trends and controversies[J]. Technol Cancer Res Treat, 2018, 17: 1533033818790217. DOI: 10.1177/1533033818790217. [7] Xiao HH, Liu LL, Li WY, et al. TLD calibration and absorbed dose measurement in a radiation-induced liver injury model under a linear accelerator[J]. Nucl Sci Tech, 2023, 34(4): 53. DOI: 10.1007/S41365-023-01211-5 [8] Lyu QH, O'Connor D, Ruan D, et al. VMAT optimization with dynamic collimator rotation[J]. Med Phys, 2018, 45(6): 2399-2410. DOI: 10.1002/MP.12915 [9] Li W, Jiang LJ, Lu XZ, et al. Curcumin protects radiation-induced liver damage in rats through the NF-κB signaling pathway[J]. BMC Complement Med Ther, 2021, 21(1): 10. DOI: 10.1186/S12906-020-03182-1 [10] Lock M, Chow R, Jayatilaka A, et al. Does stereotactic body radiation improve outcomes compared to conventional radiation for liver cancer patients?[J]. Clin Transl Radiat Oncol, 2022, 35: 17-20. DOI: 10.1016/J.CTRO.2022.04.002 [11] Xu Y, Feng S, Peng QL, et al. Single-cell RNA sequencing reveals the cell landscape of a radiation-induced liver injury mouse model[J]. Radiat Med Prot, 2021, 2(4): 181-183. DOI: 10.1016/J.RADMP.2021.11.001 [12] Melin N, Yarahmadov T, Sanchez-Taltavull D, et al. A new mouse model of radiation-induced liver disease reveals mitochondrial dysfunction as an underlying fibrotic stimulus[J]. JHEP Rep, 2022, 4(7): 100508. DOI: 10.1016/J.JHEPR.2022.100508 [13] Du SS, Chen GW, Yuan BY, et al. DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury[J]. Cell Mol Immunol, 2021, 18(7): 1718-1728. DOI: 10.1038/S41423-020-0395-X [14] 高世乐, 胡宗涛, 董六一, 等. 白芍总苷防治放射性肝损伤形成的临床研究及其作用机制[J]. 中国中药杂志,2017,42(7):1390-1394. DOI: 10.19540/j.cnki.cjcmm.20170121.038 Gao SL, Hu ZT, Dong LY, et al. Clinical efficacy and mechanism of total glucosides from white paeony for radioactive liver damage[J]. China J Chin Mater Med, 2017, 42(7): 1390-1394. DOI: 10.19540/j.cnki.cjcmm.20170121.038 [15] Im WH, Song JS, Jang W. Noninvasive staging of liver fibrosis: review of current quantitative CT and MRI-based techniques[J]. Abdom Radiol, 2022, 47(9): 3051-3067. DOI: 10.1007/S00261-021-03181-X [16] Kim J, Jung Y. Radiation-induced liver disease: current understanding and future perspectives[J]. Exp Mol Med, 2017, 49(7): e359. DOI: 10.1038/EMM.2017.85 [17] Yi L, Hu N, Mu HX, et al. Identification of cofilin-1 and destrin as potential early-warning biomarkers for gamma radiation in mouse liver tissues[J]. Health Phys, 2019, 116(6): 749-759. DOI: 10.1097/HP.0000000000001012 [18] Wu ZF, Zhang JY, Shen XY, et al. A mouse radiation-induced liver disease model for stereotactic body radiation therapy validated in patients with hepatocellular carcinoma[J]. Med Phys, 2016, 43(7): 4349-4361. DOI: 10.1118/1.4953831 [19] Kurland IJ, Broin PÓ, Golden A, et al. Integrative metabolic signatures for hepatic radiation injury[J]. PLoS One, 2015, 10(6): e0124795. DOI: 10.1371/JOURNAL.PONE.0124795 [20] Hu ZT, Qin F, Gao SL, et al. Paeoniflorin exerts protective effect on radiation-induced hepatic fibrosis in rats via TGF-β1/Smads signaling pathway[J]. Am J Transl Res, 2018, 10(3): 1012-1021 [21] Dong FF, Weng X, Deng XZ, et al. Clinical utility of a new immobilization method in image-guided intensity-modulated radiotherapy for breast cancer patients after radical mastectomy[J]. J X-Ray Sci Technol, 2022, 30(4): 641-655. DOI: 10.3233/XST-221127 [22] Salari E, Parsai EI, Shvydka D, et al. Evaluation of parameters affecting gamma passing rate in patient-specific QAs for multiple brain lesions IMRS treatments using ray-station treatment planning system[J]. J Appl Clin Med Phys, 2022, 23(1): e13467. DOI: 10.1002/ACM2.13467
